The transformative solution leverages agentic artificial intelligence (AI) and automation to enhance the accuracy, speed, and efficiency of pharmacovigilance processes

Tech Mahindra announced a pharmacovigilance (PV) autonomous solution built with NVIDIA AI software to advance drug safety management. The transformative solution leverages agentic artificial intelligence (AI) and automation to enhance the accuracy, speed, and efficiency of pharmacovigilance processes, addressing critical industry challenges such as manual delays and data overload.

Powered by Tech Mahindra's TENO framework, which is built on NVIDIA's cutting-edge AI technology, the solution is designed to automate and optimize pharmacovigilance workflows. By integrating the NVIDIA AI Enterprise software platform, including NVIDIA NeMo, NVIDIA NIM microservices, and NVIDIA AI Blueprints, the Tech Mahindra solution streamlines case intake, data transformation, quality control, and compliance management, thereby ensuring a seamless and intelligent PV workflow. Additionally, the LLM-powered AI agents within the solution autonomously handle case classification, prioritisation, and verification of pharmacovigilance emails to reduce the risk of human error.

Nikhil Malhotra, Chief Innovation Officer and Global Head of AI and Emerging Technologies, Tech Mahindra, said, "As the pharmaceutical industry navigates volumes of data during trials and post-launch, our collaboration with NVIDIA leverages generative AI and multi-agent systems to streamline pharmacovigilance process. Together, we are revolutionising drug safety management and using the innovative AI-driven framework to develop multiple use cases for our global customers."

John Fanelli, Vice President, Enterprise Software, NVIDIA, said, "AI is ideal for monitoring medicines throughout their lifecycle to support safety. Integrating AI into the Tech Mahindra TENO framework with NVIDIA AI Enterprise software enhances pharmacovigilance by augmenting human capabilities to help identify potential safety issues more effectively."